LISINOPRIL
- Product NDC
- 68071-3122
- 11-digit product format
- 680713122
- Labeler code
- 68071
- Product ID
- 68071-3122_1d9eaa76-8490-a471-e063-6394a90aef30
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA076180
- Marketing category
- ANDA
- Marketing start
- 2011-11-01
- Substance
- LISINOPRIL
- Active strength
- 10 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- LISINOPRIL
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LISINOPRIL | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | E7199S1YWR |
| Rxcui | 314076 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 68071-3122-3 | 2024-07-19 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
| 68071-3122-5 | 2024-07-19 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
| 68071-3122-6 | 2024-07-19 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
| 68071-3122-9 | 2024-07-19 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
| 68071-3122-3 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
| 68071-3122-5 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
| 68071-3122-6 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
| 68071-3122-9 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
| 68071-3122-3 | 2021-02-11 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
| 68071-3122-5 | 2021-02-11 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
| 68071-3122-6 | 2021-02-11 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
| 68071-3122-9 | 2021-02-11 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
| 68071-3122-3 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
| 68071-3122-5 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
| 68071-3122-6 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
| 68071-3122-9 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-25fc-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use Lisinopril safely and effectively. See full prescribing information for Lisinopril LISINOPRIL tablets USP, for oral use Initial U.S. Approval: 1988 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-3122-3 | LISINOPRIL | 30 in 1 BOTTLE | TABLET | 30 | | 5 |
| 68071-3122-5 | LISINOPRIL | 15 in 1 BOTTLE | TABLET | 15 | | 5 |
| 68071-3122-6 | LISINOPRIL | 60 in 1 BOTTLE | TABLET | 60 | | 5 |
| 68071-3122-9 | LISINOPRIL | 90 in 1 BOTTLE | TABLET | 90 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-3122 | LISINOPRIL TABLET [NUCARE PHARMACEUTICALS, INC.] | 5 | Current NDC, Legacy NDC, 4 package rows | 20240720_4aa518e1-d989-1fde-e054-00144ff88e88.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-3122-3 | 68071312203 | 30 TABLET in 1 BOTTLE (68071-3122-3) | 30 tablet | 2017-03-13 | 0000-00-00 | No | No | Current |
| 68071-3122-5 | 68071312205 | 15 TABLET in 1 BOTTLE (68071-3122-5) | 15 tablet | 2017-03-13 | 0000-00-00 | No | No | Current |
| 68071-3122-6 | 68071312206 | 60 TABLET in 1 BOTTLE (68071-3122-6) | 60 tablet | 2017-03-13 | 0000-00-00 | No | No | Current |
| 68071-3122-9 | 68071312209 | 90 TABLET in 1 BOTTLE (68071-3122-9) | 90 tablet | 2017-03-13 | 0000-00-00 | No | No | Current |